$SNPS

Synopsys and OpenAI Forge Revenue-Sharing Pact to Design Chips Faster

Synopsys (SNPS) and OpenAI partnered to create GPT-Synopsys, an AI model for chip design. They will share revenue from commercial use. Synopsys raised its 2027 revenue growth forecast to 15%, above analyst estimates. Shares rose 7% post-announcement. The model will integrate with Synopsys's platforms, with customer data protected.

Original reporting
Published Sep 30, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS
Relevance
8/10
AlphAI data visualization · based on finance.biggo.com
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The revenue‑sharing pact and upgraded FY2027 guidance provide a fresh growth catalyst, likely prompting short‑term buying and longer‑term sector interest.

02

Market read

The announcement combines AI innovation with a major semiconductor software vendor, offering a material growth catalyst for SNPS and potential spillover to the broader chip‑design ecosystem.

03

What to watch

Implementation risk and the need for extensive validation could delay commercial uptake, tempering near‑term revenue impact.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Synopsys (SNPS) is a leading electronic design automation (EDA) software provider. OpenAI is a leading AI research lab. Their collaboration aims to embed a specialized GPT model into Synopsys tools.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys announced a revenue‑sharing partnership with OpenAI and lifted FY2027 revenue growth guidance to 15%, sending the stock up ~7% intraday.

Expected impact

likely upside as investors price in stronger growth and AI‑enabled product offerings

Evidence & confidence

Guidance lift and a novel AI model for a core addressable market provide a clear catalyst; the stock already reacted positively, suggesting further buying pressure.

Market effects

AI‑driven EDA tools could spur broader adoption across semiconductor design firms, benefiting the wider chip‑design services sector.

U.S. semiconductor and AI software markets may see increased investor interest.

The deal highlights convergence of AI and hardware design, a theme of global relevance for tech investors.

Counterpoint

The partnership may cannibalize existing licensing revenue if customers shift to AI‑based pricing models, limiting upside.

Key entities

  • Synopsys

    U.S.-listed EDA software provider (ticker SNPS).

  • OpenAI

    AI research organization partnering with Synopsys.

Related articles

$SNPSMed

Synopsys Details Growth Strategy and Long-term Financial Model at 2026 Investor Day

Synopsys (NASDAQ: SNPS) updated its long-term growth targets at its 2026 Investor Day, expecting fiscal year 2027 revenue of $11.15 billion (15% YoY growth). The company plans to return up to 50% of free cash flow to shareholders via share repurchases, aiming to buy back $1 billion in shares. Synopsys highlighted AI-driven demand and partnerships, including a deal with Amazon and a collaboration with OpenAI for AI-powered chip design.

$SNPSHighAI 8/10

Synopsys And OpenAI Team Up On GPT-Synopsys

Synopsys and OpenAI partnered to create GPT-Synopsys, sharing revenue based on AI-driven chip design improvements. Synopsys raised its fiscal 2027 revenue growth outlook to 15%, exceeding analyst estimates. The deal introduces value-based pricing but maintains traditional verification steps, reducing AI replacement risk.

$SNPSMed

Synopsys (SNPS) Partners with OpenAI to Integrate AI into Semico

Synopsys (SNPS) announced a multi-year partnership with OpenAI to develop GPT-Synopsys, an AI-driven model for semiconductor design. The collaboration aims to optimize workflows and includes a revenue-sharing agreement. SNPS is trading at $432, 34.4% below its GF Value™ of $658.56, with a GF Score™ of 91. Insider activity shows $48.2M in sales over the past year.

$SNPSHighAI 9/10

Synopsys stock analysis: what does today’s news tell investors?

Synopsys Inc (SNPS) stock rose 4.97% to $435.70 after announcing a $1B+ multi-year deal with Amazon.com (AMZN) for silicon IP licensing. The deal introduces a new license-plus-royalty model. Additionally, Synopsys partnered with OpenAI to develop GPT-Synopsys for semiconductor design. CEO Sassine Ghazi raised FY2027 revenue growth guidance to 15%, above analyst consensus of 11.19%.

$SNPSHigh

Synopsys shares jump on GPT-Synopsys chip design deal with OpenAI

Synopsys (SNPS) and OpenAI announced a multi-year partnership to develop GPT-Synopsys, an AI model for chip design. Synopsys shares rose 4.19% to $435.50 on the news, part of a 9.94% climb over 20 trading sessions. The deal involves revenue sharing and software licensing, but financial terms were not disclosed. Synopsys reported quarterly revenue of $2.48bn and net income of $545.8m for the quarter ended 31 July 2026.